共 50 条
- [44] Comparisons of Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J-ROCKET AF Trials) in Asian Patients With Atrial Fibrillation JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (21):
- [46] Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial) AMERICAN HEART JOURNAL, 2015, 170 (04) : 675 - +